Biotech developing treatments that target cancer stem cells and tumor bulk.
Industry: Health Care
First Day Return: +18.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/02/2012 |
Offer Price | $10.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 3.3 |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/28/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2003 |
Employees at IPO | 8 |
Website www.stemline.com |